BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 34140530)

  • 1. Baseline T-lymphocyte subset absolute counts can predict both outcome and severity in SARS-CoV-2 infected patients: a single center study.
    Iannetta M; Buccisano F; Fraboni D; Malagnino V; Campogiani L; Teti E; Spalliera I; Rossi B; Di Lorenzo A; Palmieri R; Crea A; Zordan M; Vitale P; Voso MT; Andreoni M; Sarmati L
    Sci Rep; 2021 Jun; 11(1):12762. PubMed ID: 34140530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte subsets early predict mortality in a large series of hospitalized COVID-19 patients in Spain.
    Cantenys-Molina S; Fernández-Cruz E; Francos P; Lopez Bernaldo de Quirós JC; Muñoz P; Gil-Herrera J
    Clin Exp Immunol; 2021 Mar; 203(3):424-432. PubMed ID: 33187018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4 and CD8 Lymphocyte Counts as Surrogate Early Markers for Progression in SARS-CoV-2 Pneumonia: A Prospective Study.
    Calvet J; Gratacós J; Amengual MJ; Llop M; Navarro M; Moreno A; Berenguer-Llergo A; Serrano A; Orellana C; Cervantes M
    Viruses; 2020 Nov; 12(11):. PubMed ID: 33182268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation Between Relative Nasopharyngeal Virus RNA Load and Lymphocyte Count Disease Severity in Patients with COVID-19.
    Liu Y; Liao W; Wan L; Xiang T; Zhang W
    Viral Immunol; 2021 Jun; 34(5):330-335. PubMed ID: 32297828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring peripheral neutrophil and T-lymphocyte subsets could assist in differentiating the severity and disease progression of coronavirus disease 2019.
    Meng L; Xu J; Zhang J; Zhang K; Shang P; Li Q; Li Y; Wang L; Cai B
    Aging (Albany NY); 2021 Mar; 13(6):7723-7732. PubMed ID: 33741750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte subsets as a predictor of severity and prognosis in COVID-19 patients.
    Zhang P; Du W; Yang T; Zhao L; Xiong R; Li Y; Geng Y; Lu W; Zhou J
    Int J Immunopathol Pharmacol; 2021; 35():20587384211048567. PubMed ID: 34619994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated Exhaustion Levels of NK and CD8
    Li M; Guo W; Dong Y; Wang X; Dai D; Liu X; Wu Y; Li M; Zhang W; Zhou H; Zhang Z; Lin L; Kang Z; Yu T; Tian C; Qin R; Gui Y; Jiang F; Fan H; Heissmeyer V; Sarapultsev A; Wang L; Luo S; Hu D
    Front Immunol; 2020; 11():580237. PubMed ID: 33154753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific dynamic variations in the peripheral blood lymphocyte subsets in COVID-19 and severe influenza A patients: a retrospective observational study.
    Qian F; Gao G; Song Y; Xu Y; Wang A; Wang S; Hao Y; Chen M; Ma X; Zhao T; Guo X; Chen Z; Zhang F
    BMC Infect Dis; 2020 Dec; 20(1):910. PubMed ID: 33261583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study.
    Yin SW; Zhou Z; Wang JL; Deng YF; Jing H; Qiu Y
    Virol J; 2021 Jun; 18(1):126. PubMed ID: 34118952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppressed T cell-mediated immunity in patients with COVID-19: A clinical retrospective study in Wuhan, China.
    Xu B; Fan CY; Wang AL; Zou YL; Yu YH; He C; Xia WG; Zhang JX; Miao Q
    J Infect; 2020 Jul; 81(1):e51-e60. PubMed ID: 32315725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Short-Term Low-Dose Glucocorticoids for Patients with Mild COVID-19.
    Fu HY; Luo Y; Gao JP; Wang L; Li HJ; Li X; Xue L; Tang XQ; Li HW; Du YR
    Biomed Res Int; 2020; 2020():2854186. PubMed ID: 33015160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocyte Subset Alteration and Monocyte CD4 Expression Reduction in Patients with Severe COVID-19.
    Kazancioglu S; Yilmaz FM; Bastug A; Sakallı A; Ozbay BO; Buyuktarakci C; Bodur H; Yilmaz G
    Viral Immunol; 2021 Jun; 34(5):342-351. PubMed ID: 33264073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamics of cytokines and lymphocyte subsets associated with the poor prognosis of severe COVID-19.
    Li Q; Xu W; Li WX; Huang CL; Chen L
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12536-12544. PubMed ID: 33336774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-Cell Subset Counts in Peripheral Blood Can Be Used as Discriminatory Biomarkers for Diagnosis and Severity Prediction of Coronavirus Disease 2019.
    Jiang M; Guo Y; Luo Q; Huang Z; Zhao R; Liu S; Le A; Li J; Wan L
    J Infect Dis; 2020 Jun; 222(2):198-202. PubMed ID: 32379887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The predictive role of lymphocyte subsets and laboratory measurements in COVID-19 disease: a retrospective study.
    Wang L; Chen J; Zhao J; Li F; Lu S; Liu P; Liu XH; Huang Q; Wang H; Xu QN; Liu X; Yu S; Liu L; Lu H
    Ther Adv Respir Dis; 2021; 15():17534666211049739. PubMed ID: 34632871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk Factors for Mortality of COVID-19 Patient Based on Clinical Course: A Single Center Retrospective Case-Control Study.
    Zhang J; Wang Z; Wang X; Hu Z; Yang C; Lei P
    Front Immunol; 2021; 12():581469. PubMed ID: 33664741
    [No Abstract]   [Full Text] [Related]  

  • 17. Dynamic changes in lymphocyte subsets and parallel cytokine levels in patients with severe and critical COVID-19.
    Liu Y; Tan W; Chen H; Zhu Y; Wan L; Jiang K; Guo Y; Tang K; Xie C; Yi H; Kuang Y; Luo Y
    BMC Infect Dis; 2021 Jan; 21(1):79. PubMed ID: 33461503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the Levels of Peripheral CD3
    Aljabr W; Al-Amari A; Abbas B; Karkashan A; Alamri S; Alnamnakani M; Al-Qahtani A
    Microbiol Spectr; 2022 Feb; 10(1):e0084521. PubMed ID: 35196808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral blood CD4+ cell counts but not CD3+ and CD8+ cell counts are reduced in SARS-CoV-2 infection.
    Huang ZX; Li W; Lu E; Yan X; Lin J; Zhuo L
    J Affect Disord; 2020 Dec; 277():375-378. PubMed ID: 32861838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell counts and IL-6 concentration in blood of North African COVID-19 patients are two independent prognostic factors for severe disease and death.
    Belaid B; Lamara Mahammad L; Mihi B; Rahali SY; Djidjeli A; Larab Z; Berkani L; Berkane I; Sayah W; Merah F; Lazli NZ; Kheddouci L; Kadi A; Ouali M; Khellafi R; Mekideche D; Kheliouen A; Ayoub S; Hamidi RM; Derrar F; Gharnaout M; Allam I; Djidjik R
    J Leukoc Biol; 2022 Jan; 111(1):269-281. PubMed ID: 33527487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.